Direkt zum Inhalt
Merck

E5160

Sigma-Aldrich

Epidermal Growth Factor from mouse

≥90% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable for cell cutlure

Synonym(e):

Mouse EGF, Mouse Epidermal Growth Factor

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352202
NACRES:
NA.77

product name

Epidermal Growth Factor from mouse, EGF

Biologische Quelle

mouse

Qualitätsniveau

Rekombinant

expressed in E. coli

Assay

≥90% (SDS-PAGE)

Form

lyophilized powder

Wirksamkeit

0.05-1 ng/mL ED50/EC50

Mol-Gew.

~6 kDa

Verpackung

pkg of 100 μg

Lagerbedingungen

avoid repeated freeze/thaw cycles

Methode(n)

cell culture | mammalian: suitable

Verunreinigungen

≤1 EU/μg endotoxin (Protein)

Farbe

white

Löslichkeit

water: soluble 0.10 mL, clear, colorless

UniProt-Hinterlegungsnummer

Lagertemp.

−20°C

Angaben zum Gen

mouse ... Egf(13645)

Allgemeine Beschreibung

Epidermal Growth Factor (EGF) is a small mitogenic polypeptide (∼6kDa) present in many mammalian species and distributed throughout a wide number of tissues and body fluids. Four ErbB (HER) family receptor tyrosine kinases, including EGFR/ErbB1, ErbB2, ErbB3, and ErbB4 mediate responses to EGF family members. Human and mouse EGFs are very similar, but not identical in their physical and chemical properties. Of the 53 amino acid residues comprising each of the two polypeptides, 37 are common to both molecules, and three disulfide bonds are formed in the same relative positions.

Anwendung

Epidermal Growth Factor from mouse has been used as a basal (N2B27) medium supplement for culturing differentiated mouse embryonic stem (E14) cells.

Biochem./physiol. Wirkung

EGF (epidermal growth factor) is involved in cellular proliferation, differentiation, and survival. Moreover, it was found to affect various biological activities like angiogenesis, inhibition of gastric acid secretion, modulation of the synthesis of a number of hormones, synthesis and turn-over of proteins of the extracellular matrix, calcium release from bone tissue (thus promoting bone resorption), chemoattraction of fibroblasts and epithelial cells, and alone or in combination with other cytokines, mediation of wound healing processes. EGF is mitogenic for a large variety cell types, including fibroblasts, epithelial cells, endothelial cells, chondrocytes, and SV40-3T3 cells.

Physikalische Form

The product is lyophilized from a 0.2 μm-filtered solution of phosphate buffered saline (PBS), pH 7.4.

Quellenangabe

1. Carpenter, G., and Cohen, S., Epidermal growth factor. Annu. Rev. Biochem., 48, 193-216 (1979).
2. Jorissen, R.N., et al., Epidermal growth factor: mechanisms of activation and signaling. Exp. Cell Res., 284, 31-53 (2003).
3. Herbst, R.S., Review of epidermal growth factor receptor biology. Int.J. Radiat. Oncol. Biol., Phys., 59, S21-S26 (2004).
4. Mehta, V.B., and Besner, G.E., HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors, 25, 253-263 (2007).
5. Bower, J.M., et al., The inhibition of gastric acid secretion by epidermal growth factor. Experientia, 31, 825-826 (1975).
6. Schonbrunn, A., et.al., Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation. J. Cell Biol., 85, 786-797 (1980).
7. Mimura, Y., et al., Epidermal growth factor induces fibronectin expression in human dermal fibroblasts via protein kinase C delta signaling pathway. J. Invest. Dermatol., 122, 1390-1398 (2004).
8. Warner, M.R. et al., Ametantrone inhibits prostaglandin-mediated resorption in bone organ culture. Prostaglandins, 28, 469-476 (1984).
9. Grotendorst, G.R., et al., EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J. Cell. Physiol., 139, 617623 (1989).
10. Schultz, G., et al., EGF and TGF-alpha in wound healing and repair. J. Cell. Biochem., 45, 346-352 (1991).
11. George-Nascimento, C., et al., Characterization of recombinant human epidermal growth factor produced in yeast. Biochemistry, 27, 797-802 (1988).

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 1


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Epidermal growth factor.
Carpenter G and Cohen S
Annual Review of Biochemistry, 48, 193-193 (1979)
Review of epidermal growth factor receptor biology.
Herbst RS
International Journal of Radiation Oncology, Biology, Physics, 59, S21-S21 (2004)
Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain.
Schonbrunn A et al.
The Journal of Cell Biology, 85, 786-786 (1980)
EGF and TGF-alpha in wound healing and repair.
Schultz G et al.
Journal of Cellular Biochemistry, 45, 346-346 (1991)
Ametantrone inhibits prostaglandin-mediated resorption in bone organ culture.
Warner MR et al.
Prostaglandins, 28, 469-469 (1984)

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.